• Back to miR-21-5p

• Kao, H. W., et al. Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget (2017).
• Shi, Rui, et al. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget 6.29 (2015): 26971.
• Peng, Qiliang, et al. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget 5 (2017).
• Khalid, Usman, et al. MicroRNA‐21 (miR‐21) expression in hypothermic machine perfusate may be predictive of early outcomes in kidney transplantation. Clinical transplantation 30.2 (2016): 99-104.
• Wang, Jialu, et al. Differential expression of circulating microRNAs in blood and haematoma samples from patients with intracerebral haemorrhage. Journal of International Medical Research 44.3 (2016): 419-432.
• Parikh, Victoria N., et al. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. Journal of acquired immune deficiency syndromes (1999) 70.3 (2015): 236-241.
• Elbehidy, Rabab M., et al. MicroRNA–21 as a novel biomarker in diagnosis and response to therapy in asthmatic children. Molecular immunology 71 (2016): 107-114.
• Zhang, Y., et al. Plasma microRNA-21 is a potential diagnostic biomarker of acute myocardial infarction. Eur Rev Med Pharmacol Sci 20.2 (2016): 323-329.
• Olivieri, Fabiola, et al. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications. Oncotarget 6.34 (2015): 35372.
• Qu, Kai, et al. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Scientific Reports 7 (2017).
• Migita, Kiyoshi, et al. Circulating microRNA profiles in patients with type-1 autoimmune hepatitis. PloS one 10.11 (2015): e0136908.